MYD88, CARD11, and CD79B oncogenic mutations are rare events in the Indian cohort of de novo nodal diffuse large B-cell lymphoma

V Aggarwal, A Das, A Bal, R Srinivasan… - Applied …, 2019 - journals.lww.com
Diffuse large B-cell lymphoma (DLBCL) has a heterogenous biological behavior, and the
western literature has reported activating oncogenic mutations in myeloid differentiation …
被引用次数：13 相关文章

MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.

V Aggarwal, A Das, A Bal, R Srinivasan… - Applied …, 2019 - europepmc.org
Diffuse large B-cell lymphoma (DLBCL) has a heterogenous biological behavior, and the
western literature has reported activating oncogenic mutations in myeloid differentiation …

MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma

V Aggarwal, A Das, A Bal, R Srinivasan… - Applied …, 2019 - ingentaconnect.com
Diffuse large B-cell lymphoma (DLBCL) has a heterogenous biological behavior, and the
western literature has reported activating oncogenic mutations in myeloid differentiation …

MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma

V Aggarwal, A Das, A Bal… - Applied …, 2019 - pubmed.ncbi.nlm.nih.gov
Diffuse large B-cell lymphoma (DLBCL) has a heterogenous biological behavior, and the
western literature has reported activating oncogenic mutations in myeloid differentiation …